全文获取类型
收费全文 | 692篇 |
免费 | 68篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 50篇 |
妇产科学 | 3篇 |
基础医学 | 176篇 |
口腔科学 | 3篇 |
临床医学 | 42篇 |
内科学 | 216篇 |
皮肤病学 | 111篇 |
神经病学 | 15篇 |
特种医学 | 7篇 |
外科学 | 37篇 |
综合类 | 25篇 |
预防医学 | 15篇 |
眼科学 | 7篇 |
药学 | 25篇 |
中国医学 | 4篇 |
肿瘤学 | 13篇 |
出版年
2024年 | 1篇 |
2023年 | 10篇 |
2022年 | 27篇 |
2021年 | 33篇 |
2020年 | 34篇 |
2019年 | 37篇 |
2018年 | 30篇 |
2017年 | 33篇 |
2016年 | 36篇 |
2015年 | 21篇 |
2014年 | 47篇 |
2013年 | 54篇 |
2012年 | 26篇 |
2011年 | 19篇 |
2010年 | 17篇 |
2009年 | 19篇 |
2008年 | 25篇 |
2007年 | 22篇 |
2006年 | 27篇 |
2005年 | 19篇 |
2004年 | 11篇 |
2003年 | 30篇 |
2002年 | 12篇 |
2001年 | 16篇 |
2000年 | 10篇 |
1999年 | 16篇 |
1998年 | 12篇 |
1997年 | 9篇 |
1996年 | 16篇 |
1995年 | 10篇 |
1994年 | 10篇 |
1993年 | 8篇 |
1992年 | 13篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1989年 | 5篇 |
1988年 | 4篇 |
1987年 | 5篇 |
1986年 | 7篇 |
1985年 | 4篇 |
1984年 | 2篇 |
1983年 | 2篇 |
1982年 | 1篇 |
1981年 | 7篇 |
1980年 | 3篇 |
1979年 | 4篇 |
1978年 | 2篇 |
1975年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有765条查询结果,搜索用时 31 毫秒
101.
The 8p11 myeloproliferative syndrome (EMS), also known as 8p11 myeloproliferative neoplasm (8p11 MPN), is a collection of rare hematologic malignancies that are associated with fusion genes involving the tyrosine kinase receptor gene FGFR1 in chromosome 8p11. The entity is an aggressive disease with a high rate of transformation to acute myeloid leukemia (AML) and pathologically characterized by its associated eosinophilia. In this study, we reported a distinctive EMS case featuring an in-frame ZMYM2-FGFR1 fusion gene identified by next-generation sequencing technology (NGS). This patient exhibited not only typical EMS signs including elevated white blood cells in peripheral blood and hypercellular bone marrow with marked leukocytosis, but also exceptional characteristics including erythrocytosis in blood and bone marrow basophilia. Moreover, we detected 2 novel genomic mutations in 2 known leukemogenic genes, IKZF1 and ASXL1. Whether these 2 mutations play a part in EMS pathogenesis or contribute to its specific presentations clinically remain to be determined. In summary, we present a unique EMS case involving a ZMYM2-FGFR1 fusion with distinctive hematologic characteristics. 相似文献
102.
Austin Blackburn Wiles Adele O. Kraft Sandra M. Mueller Celeste N. Powers 《Diagnostic cytopathology》2019,47(6):589-593
Sclerosing mucoepidermoid carcinoma with eosinophilia (SMECE) is a rare primary cancer of the thyroid. This tumor is analogous to other primary tumors of the salivary glands, breast, pancreas, and esophagus. We present a case of this rare tumor with characteristic clinical features, ultrasound images, cytopathology, histopathology, and a heretofore undocumented somatic gene mutation. Additionally, we provide a succinct review of the controversial literature for this uncommon lesion. 相似文献
103.
Eduardo Ruchelli William Wenner Theresa Voytek Kurt Brown Chris Liacouras 《Pediatric and developmental pathology》1999,2(1):15-18
Pediatric patients who present with symptoms of gastroesophageal reflux and severe eosinophilic esophagitis may be unresponsive
to aggressive anti-reflux medical therapy. In order to determine whether the degree of eosinophilia predicts anti-reflux treatment
response and possibly distinguishes different etiologies, we reviewed the initial biopsies of patients with esophageal eosinophilia
and compared the number of eosinophils with the response to anti-reflux treatment. Over a 1-year period, 102 patients with
a biopsy demonstrating at least 1 intraepithelial eosinophil were identified among patients undergoing initial endoscopy for
symptoms of reflux. All patients were treated with H2 blockers and prokinetic agents. Treatment response was classified into
three categories: improvement, relapse, and failure. There were significant differences between the group who improved (mean
eosinophil count [MEC] 1.1 ± 0.3 SEM) and those who failed (24.5 ± 6.1 SEM, P < 0.0025) or relapsed 6.4 ± 2.4 SEM, P < 0.05). A threshold MEC value of ≥7 provided a sensitivity of 61.3%, a specificity of 95.7%, and a predictive value for
treatment failure of 86.1. A MEC value of <7 provided an 85% predictive value of successful therapy. From these data we made
the following conclusions: (1) The number of eosinophils has a predictive value of treatment response with ≥7 per high power field offering a valuable
clinical threshold for predicting outcome of conventional therapy. (2) The variable response to conventional reflux treatment may reflect different etiologies. (3) Alternate medical treatment modalities may be appropriate in the presence of severe eosinophilia, before considering surgical
intervention.
Received October 17, 1997; accepted March 27, 1998. 相似文献
104.
M Okano DA Harn Jr M Abe MM Wang AR Satoskar K Nishizaki Y Masuda M Okano T Yoshino 《Allergy》1999,54(6):593-601
BACKGROUND: To date, no murine models have been reported to show the induction of both antigen-specific IgE and nasal eosinophilia, two of the major hallmarks of allergic rhinitis, after local sensitization in the absence of adjuvants, a phenomenon which reflects natural exposure. In this report, we attempted to establish a murine model representing an initiation of allergic rhinitis. METHODS: BALB/c, CBA/J, and C57BL/6 mice were sensitized intranasally to Schistosoma mansoni egg antigen (SEA) solely. After repeated sensitization, serum Ab titers, nasal eosinophilia, and cytokine production by nasal lymphocytes were determined. RESULTS: BALB/c mice produced SEA-specific IgE after repeated sensitization. High-dose sensitization to SEA induced IgE production in CBA/J mice, while C57BL/6 mice did not show the production throughout the period observed, suggesting that IgE production was regulated genetically. BALB/c mice also exhibited nasal eosinophilia after the nasal challenge. In addition, nasal lymphocytes sensitized with SEA intranasally produced significant amount of IL-5 in vitro. CONCLUSIONS: These results suggest that intranasal sensitization with SEA in the absence of adjuvants induces a Th2 immune reaction, reflecting the hallmarks of the initiation of allergic rhinitis both in vivo and in vitro, which is genetically regulated. 相似文献
105.
Ines Misselevich Michael Luria Shelton Malatskey Milo Fradis Ludwig Podoshin Jochanan H. Boss 《Diagnostic cytopathology》1998,18(3):227-229
Whereas evaluation of the frozen section of a subcutaneous retro-auricular mass was equivocal, the correct diagnosis of epithelioid hemangioma could be suggested on examination of intraoperative cytological smears. It is proposed that in the absence of cytological cues of malignancy and in the presence of the proper clinical setting, the constellation of vascular structures, eosinophils, lymphocytes, and clusters of cuboidal cells with vacuoles in their abundant acidophilic cytoplasm is indicative of epithelioid hemangioma. Diagn. Cytopathol. 1998;18:227–229. © 1998 Wiley-Liss, Inc. 相似文献
106.
Masao Ogata Yuko Ogata Kazuhiro Kohno Noritaka Uno Eiji Ohno Eiichi Ohtsuka Yoshio Saburi Perparim Kamberi Masaru Nasu Hiroshi Kikuchi 《American journal of hematology》1998,59(3):242-245
To clarify the mechanism of eosinophilia in adult T-cell leukemia (ATL), we studied three ATL patients having marked eosinophilia. Eosinophil-predominant colony-stimulating activity was detected in the serum of one patient and in the conditioned media (CM) from cultured ATL cells from two patients. Soluble interleukin 5 (IL-5), but no interleukin 3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF), was detected in sera from all patients. On the other hand, GM-CSF was produced in vitro by ATL cells from all cases, whereas detectable IL-3 and IL-5 was produced by cells from only one, suggesting that in the other two cases, the serum IL-5 was produced by the normal reacting lymphocytes. The fact that no patient showed marked neutrophilia supports the possibility that IL-5 may have a leading role in the development of eosinophilia, with GM-CSF produced by ATL cells playing a complementary role. Am. J. Hematol. 59:242–245, 1998. © 1998 Wiley-Liss, Inc. 相似文献
107.
Norihisa Ishimura Yoshikazu Kinoshita 《Journal of gastroenterology and hepatology》2018,33(5):1016-1022
Eosinophilic esophagitis (EoE) is a chronic inflammatory condition characterized by esophageal dysfunction and dense eosinophilic infiltration of esophageal epithelium. According to clinical consensus and guidelines published in 2011, esophageal eosinophilia was classified into two entities based on response to proton pump inhibitor (PPI) administration: EoE and PPI‐responsive esophageal eosinophilia (PPI‐REE). We have performed a series of investigations to determine whether EoE is actually different from PPI‐REE. Consistent with Western reports, more than half of our examined patients with symptomatic esophageal eosinophilia suggestive of EoE achieved histological remission with single PPI therapy. Furthermore, our comparisons of clinical, endoscopic, and histopathological findings between patients with EoE and those with PPI‐REE revealed nearly no differences between them. We also compared gene expression profiles in mucosal biopsy specimens between those groups and found that microarray findings obtained from PPI‐REE patients substantially overlapped with those from EoE patients, suggesting that both represent the same condition or are variations of a single disease. In addition, we have noted that more than half of EoE patients who show resistance to a PPI therapy respond to vonoprazan, a novel potassium‐competitive acid blocker that has been shown to provide more potent and sustained suppression of gastric acid secretion than PPIs. Our results indicate that PPI‐REE may constitute a subtype of EoE. Based on novel evidence including results obtained in our studies, the most recently updated guidelines have included responders to PPI therapy within the spectrum of EoE, abandoning the term PPI‐REE. 相似文献
108.
109.
Zhongyi Xu Jie Shen Yiwen Yang Ruoyue Yuan Leihong Flora Xiang Chengfeng Zhang 《ANNALS OF DERMATOLOGY》2019,31(5):545
BackgroundSevere cutaneous adverse reactions (SCAR) to drugs are a crucial public health issue and the use of systemic corticosteroids in SCAR has been controversial.ObjectiveTo analyze clinical features, causative drugs, treatment, outcomes, and prognostic factors of SCAR in the case-series of 173 patients, and add more information to the debate of using systemic corticosteroids in SCAR management.MethodsA retrospective study of 173 SCAR patients diagnosed with drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) or acute generalized exanthematous pustulosis (AGEP) at a tertiary care institution in China between January 2014 and December 2017 was conducted.ResultsOf 173 patients, allopurinol, carbamazepine, and antibiotics are the most frequently implicated drugs for DRESS (40.4%), SJS/TEN (26.0%), and AGEP (40.0%) respectively. Moreover, there is a strongly negative correlation between early corticosteroids use and the progression (p=0.000) and severity (p=0.01) of skin lesions. However, there is no association between early corticosteroids use and the mortality of SCAR (odds ratio: 1.01, 95% confidence interval: 0.95~1.08). In addition, lymphadenopathy, eosinophilia, and interval from onset to corticosteroids treatment were correlated with SCAR prognosis.ConclusionPrompt short-course systemic corticosteroids use is associated with early-stage skin lesions remission without influencing the disease mortality. Lymphadenopathy and eosinophilia were the independent poor prognostic factors of SCAR. 相似文献
110.
Functional dyspepsia (FD) is a highly prevalent disorder that affects more than 10% of the population. In the past decade, the theoretical underpinning of the concept of FD has begun to change, in light of new data on the underlying pathophysiological mechanisms of this disorder, with a focus on the duodenum. The Rome IV criteria, published in 2016, note that gastroesophageal reflux disease and irritable bowel syndrome overlap with FD more than expected by chance, suggesting that they may be part of the same disease spectrum. Infection by Helicobacter pylori (H. pylori) may explain a minority of cases of FD and in the Rome IV criteria H. pylori‐associated dyspepsia (defined as symptom relief after eradication therapy) is considered a separate entity. Duodenal inflammation characterized by increased eosinophils and in some cases mast cells, may impair the intestinal barrier. Post‐infectious gastroenteritis is now an established risk factor for FD. Other risk factors may include atopy, owning herbivore pets and exposure to antibiotics, together with gastroduodenal microbiome disturbances. Small bowel homing T cells and increased cytokines in the circulation occur in FD, correlating with slow gastric emptying, and a possible association with autoimmune rheumatological disease supports background immune system activation. A genetic predisposition is possible. FD has been linked to psychological disorders, but in some cases psychological distress may be driven by gut mechanisms. Therapeutic options are limited and, aside from responders to H. pylori eradication, provide only modest and temporary relief. Advances in understanding FD may alter clinical practice, and the treatment of duodenal inflammation or microbiome alterations may lead to a cure for a subset of these patients in the future. 相似文献